| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |